BNGO News and Press, Bionano Genomics Inc. From 03/07/23

2023-03-07 09:45:00 ET Getting in on the ground level with a stock that's on track to grow massively is one of the better things you can do for your portfolio's health. No doubt, early-stage businesses are riskier and you could lose 100% of your money, but there's also the possibility of hu...

2023-03-06 15:51:02 ET Bionano Genomics, Inc. (BNGO) Cowen 43rd Annual Healthcare Conference March 06, 2023, 01:30 PM ET Company Participants Erik Holmlin - Chief Executive Officer Conference Call Participants Tom Stevens - Life Science Tools & Diagnostic...

With the stock falling 37.8% over the last 12 months, shareholders of Bionano Genomics (NASDAQ: BNGO) are bound to be getting a bit frustrated. The genome mapping device manufacturer's fortunes haven't done anything but improve in recent memory, but the market's reception to its successes...

Peer-reviewed publication from Iqbal, et al. describes the multi-site evaluation of optical genome mapping (OGM) for postnatal genetic disorders with 404 samples and shows: Concordance of OGM against various standard of care (SOC) methods –99.5% [399 out of 401 samples] First-p...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Despite the “hotter-than-expected” U.S. inflation data reported on Feb. 24, the fundamentals of the U.S. economy remain pretty strong. But don’t take my word for it; listen to the CEO of JPMorgan, Jamie Di...

SAN DIEGO, March 01, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Thursday, March 9 th , 2023 at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and year end 2022...

SAN DIEGO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that company management will present at the 43rd Annual Cowen Healthcare Conference. Erik Holmlin, Ph.D., Bionano’s president and chief executive officer, is scheduled to ...

Bionano original equipment manufacturing (OEM) partner Beijing Genome Precision Technology (BGPT) obtained reagent class I registration and approval for DNA isolation and labeling kits from China's National Medical Products Administration (NMPA) Reagents can be utilized for in vitro ...

The following slide deck was published by Bionano Genomics, Inc. in conjunction with this event. For further details see: Bionano Genomics (BNGO) Investor Presentation - Slideshow

Bionano leaders presented on the ability of optical genome mapping (OGM) to potentially replace traditional cytogenetic methods for structural variant (SV) detection and shared details of the company’s new product advancements Bionano and NVIDIA previewed their collaborative de...